Robert Stott

In a Healio video exclusive, Edward V. Loftus Jr., MD , warned that, despite being the smallest virus capable of causing human disease, hepatitis

Key takeaways: FDA panel voted 13 to 1 that confirmatory trials did not verify clinical benefits of Ocaliva in primary biliary cholangitis.

In a Healio video exclusive, Edward V. Loftus Jr., MD , noted that the booming popularity in glucagon-like peptide-1 agonists have spurred an interspecialty “dilemma” regarding aspiration risks in the endoscopy suite.

The long-stagnant primary biliary cholangitis drug market has seen renewed attention in the past 3 months with the addition of two FDA-approved therapy options as well a costly ruling from an FDA advisory committee.

Healio Disruptive Innovator Awards. Each of the awardees in the nine categories represent the core of gastroenterology and hepatology as they seek to innovate and disrupt the practice of medicine.

“Pancreatic focal lesions, either cystic or solid, are commonly found in imaging exams,” Miguel Mascarenhas, MD, PhD from the University

“While lifestyle interventions have yielded transient and modest effect sizes, surgical interventions [for obesity] have produced the

eosinophilic esophagitis at 48 weeks, according to data presented at the ACG Annual Scientific Meeting.

Key takeaways: No efficacy difference for IBD was found between infliximab-dyyb monotherapy or in combination with immunosuppressants.

primary biliary cholangitis , according to late-breaking data presented here.